JPS6251274B2 - - Google Patents
Info
- Publication number
- JPS6251274B2 JPS6251274B2 JP55044764A JP4476480A JPS6251274B2 JP S6251274 B2 JPS6251274 B2 JP S6251274B2 JP 55044764 A JP55044764 A JP 55044764A JP 4476480 A JP4476480 A JP 4476480A JP S6251274 B2 JPS6251274 B2 JP S6251274B2
- Authority
- JP
- Japan
- Prior art keywords
- antibiotic
- positive
- substance
- following
- acid addition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- YRMCBQLZVBXOSJ-PCFSSPOYSA-N (e)-3-[(6r,6as)-4-hydroxy-6-methoxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]prop-2-enamide Chemical compound CO[C@H]1NC2=C(O)C(C)=CC=C2C(=O)N2C=C(\C=C\C(N)=O)C[C@@H]12 YRMCBQLZVBXOSJ-PCFSSPOYSA-N 0.000 claims description 15
- 230000003115 biocidal effect Effects 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- 239000003242 anti bacterial agent Substances 0.000 claims description 7
- 241000187844 Actinoplanes Species 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 239000012458 free base Substances 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 4
- 239000000741 silica gel Substances 0.000 claims 4
- 229910002027 silica gel Inorganic materials 0.000 claims 4
- 229960001866 silicon dioxide Drugs 0.000 claims 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 claims 2
- 238000000862 absorption spectrum Methods 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 238000007796 conventional method Methods 0.000 claims 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims 1
- 241000187712 Actinoplanes sp. Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 1
- 229920005654 Sephadex Polymers 0.000 claims 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- 239000002585 base Substances 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 238000004440 column chromatography Methods 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- IYWCBYFJFZCCGV-UHFFFAOYSA-N formamide;hydrate Chemical compound O.NC=O IYWCBYFJFZCCGV-UHFFFAOYSA-N 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- -1 hydroxy, chloro-substituted phenyl-glycine Chemical class 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000155 melt Substances 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 229960003104 ornithine Drugs 0.000 claims 1
- 238000004816 paper chromatography Methods 0.000 claims 1
- 239000003208 petroleum Substances 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000004809 thin layer chromatography Methods 0.000 claims 1
- 241000186361 Actinobacteria <class> Species 0.000 description 2
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000035425 carbon utilization Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G49/00—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00
- C10G49/02—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used
- C10G49/08—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used containing crystalline alumino-silicates, e.g. molecular sieves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J29/00—Catalysts comprising molecular sieves
- B01J29/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/20—Silicates
- C01B33/26—Aluminium-containing silicates, i.e. silico-aluminates
- C01B33/28—Base exchange silicates, e.g. zeolites
- C01B33/2807—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures
- C01B33/2884—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures the aluminium or the silicon in the network being partly replaced
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
- C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
- C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
- C07C1/0425—Catalysts; their physical properties
- C07C1/043—Catalysts; their physical properties characterised by the composition
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
- C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
- C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
- C07C1/0425—Catalysts; their physical properties
- C07C1/043—Catalysts; their physical properties characterised by the composition
- C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
- C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
- C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
- C07C1/0425—Catalysts; their physical properties
- C07C1/043—Catalysts; their physical properties characterised by the composition
- C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
- C07C1/044—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof containing iron
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G35/00—Reforming naphtha
- C10G35/04—Catalytic reforming
- C10G35/06—Catalytic reforming characterised by the catalyst used
- C10G35/065—Catalytic reforming characterised by the catalyst used containing crystalline zeolitic molecular sieves, other than aluminosilicates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2529/00—Catalysts comprising molecular sieves
- C07C2529/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites, pillared clays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/045—Actinoplanes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/827—Actinoplanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Geology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7912298 | 1979-04-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5697237A JPS5697237A (en) | 1981-08-05 |
| JPS6251274B2 true JPS6251274B2 (enEXAMPLES) | 1987-10-29 |
Family
ID=10504421
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4476480A Granted JPS5697237A (en) | 1979-04-07 | 1980-04-07 | Antibiotic aa16686 and its manufacture |
| JP62088966A Granted JPS62282579A (ja) | 1979-04-07 | 1987-04-13 | 抗生物質ａ／１６６８６生産菌 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62088966A Granted JPS62282579A (ja) | 1979-04-07 | 1987-04-13 | 抗生物質ａ／１６６８６生産菌 |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US4303646A (enEXAMPLES) |
| JP (2) | JPS5697237A (enEXAMPLES) |
| AR (1) | AR222217A1 (enEXAMPLES) |
| AT (1) | AT370130B (enEXAMPLES) |
| AU (2) | AU533951B2 (enEXAMPLES) |
| BE (1) | BE882632A (enEXAMPLES) |
| CA (1) | CA1142866A (enEXAMPLES) |
| CH (1) | CH655515B (enEXAMPLES) |
| DE (1) | DE3013246A1 (enEXAMPLES) |
| DK (1) | DK149336C (enEXAMPLES) |
| ES (1) | ES490236A0 (enEXAMPLES) |
| FI (1) | FI65630C (enEXAMPLES) |
| FR (1) | FR2452931A1 (enEXAMPLES) |
| GR (1) | GR67279B (enEXAMPLES) |
| HK (1) | HK23584A (enEXAMPLES) |
| HU (1) | HU181534B (enEXAMPLES) |
| IE (1) | IE49327B1 (enEXAMPLES) |
| IL (1) | IL59704A (enEXAMPLES) |
| IT (1) | IT1212411B (enEXAMPLES) |
| LU (1) | LU82327A1 (enEXAMPLES) |
| MX (1) | MX5958E (enEXAMPLES) |
| NL (1) | NL192989C (enEXAMPLES) |
| NO (1) | NO155496C (enEXAMPLES) |
| NZ (1) | NZ193357A (enEXAMPLES) |
| PH (1) | PH17230A (enEXAMPLES) |
| PT (1) | PT71064A (enEXAMPLES) |
| SE (1) | SE441188B (enEXAMPLES) |
| SG (1) | SG22687G (enEXAMPLES) |
| YU (1) | YU41917B (enEXAMPLES) |
| ZA (1) | ZA801629B (enEXAMPLES) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3163075D1 (en) | 1980-08-16 | 1984-05-17 | Lepetit Spa | Antibiotic a/16686 factor a2, the process for the preparation thereof, and the co-produced antibiotic a/16686 factors a1 and a3 |
| US4375513A (en) * | 1980-12-18 | 1983-03-01 | Eli Lilly And Company | Biologically pure culture of Actinoplanes missouriensis |
| US4859599A (en) * | 1984-10-11 | 1989-08-22 | The Dow Chemical Company | Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes |
| US4613503A (en) * | 1984-10-11 | 1986-09-23 | The Dow Chemical Company | Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes |
| GB8624806D0 (en) * | 1986-10-16 | 1986-11-19 | Pfizer Ltd | Glycopeptide antibiotic |
| GB8720980D0 (en) * | 1987-09-07 | 1987-10-14 | Lepetit Spa | Derivatives |
| GB8729989D0 (en) * | 1987-12-23 | 1988-02-03 | Lepetit Spa | Novel hydrogenated derivatives of antibiotic a/16686 |
| GB8808658D0 (en) * | 1988-04-13 | 1988-05-18 | Lepetit Spa | Aglycons of a/16686 antibiotics |
| US20030113715A1 (en) * | 2000-01-21 | 2003-06-19 | Daniel Santi | Method for cloning polyketide synthase genes |
| US7257562B2 (en) * | 2000-10-13 | 2007-08-14 | Thallion Pharmaceuticals Inc. | High throughput method for discovery of gene clusters |
| DE60109952T2 (de) * | 2000-10-13 | 2006-02-09 | Ecopia Biosciences Inc., Saint-Laurent | Ramoplaninbiosynthesegenkluster |
| US20030211567A1 (en) * | 2001-07-24 | 2003-11-13 | Ecopia Biosciences, Inc. | Compositions, methods and systems for discovery of lipopeptides |
| US7169890B2 (en) | 2002-03-08 | 2007-01-30 | Vicuron Pharmaceuticals Inc. | Process for the production of ramoplanin-like amide derivatives |
| WO2003089641A2 (en) * | 2002-04-17 | 2003-10-30 | Ecopia Biosciences Inc. | Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems |
| WO2003103699A1 (en) * | 2002-06-06 | 2003-12-18 | Vicuron Pharmaceuticals Inc. | Use of ramoplanin to treat diseases associated with the use of antibiotics |
| WO2004017925A2 (en) * | 2002-08-23 | 2004-03-04 | Genome Therapeutics Corporation | Methods and reagents for preventing bacteremias |
| US20040127403A1 (en) * | 2002-09-06 | 2004-07-01 | Francesco Parenti | Methods for treating and preventing Gram-positive bacteremias |
| CA2523573A1 (en) * | 2003-04-25 | 2004-11-11 | Oscient Pharmaceuticals Corporation | Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility |
| US20170028016A1 (en) | 2014-04-16 | 2017-02-02 | Nanotherapeutics, Inc. | Methods of treatment of c. difficile spores with ramoplanin |
| US20180002741A1 (en) | 2016-07-01 | 2018-01-04 | The United States Of America As Represented By The Department Of Veterans Affairs | Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE790627A (fr) * | 1971-10-27 | 1973-04-27 | Lilly Co Eli | L'antibiotique a477 et son procede de preparation |
| GB1458512A (en) * | 1973-11-22 | 1976-12-15 | Lepetit Spa | Antibiotic substance |
| US4038383A (en) * | 1975-01-17 | 1977-07-26 | Pfizer Inc. | Mixture of antibiotics produced by a species of actinoplanes |
| US4001397A (en) * | 1975-08-11 | 1977-01-04 | Pfizer Inc. | Antibiotic compound 41,012 |
| US4115552A (en) * | 1976-04-19 | 1978-09-19 | Eli Lilly And Company | Factor A and B of antibiotic A-4696 |
| US4169887A (en) * | 1978-02-21 | 1979-10-02 | Pfizer Inc. | Antibiotics produced by species of actinoplanes |
| JPS54135703A (en) * | 1978-04-11 | 1979-10-22 | Dainippon Pharmaceut Co Ltd | Antibiotic ab-102 and preparation thereof |
-
1980
- 1980-03-20 ZA ZA00801629A patent/ZA801629B/xx unknown
- 1980-03-21 FI FI800881A patent/FI65630C/fi not_active IP Right Cessation
- 1980-03-22 GR GR61511A patent/GR67279B/el unknown
- 1980-03-25 IL IL59704A patent/IL59704A/xx unknown
- 1980-03-25 NO NO800869A patent/NO155496C/no unknown
- 1980-03-31 US US06/135,560 patent/US4303646A/en not_active Expired - Lifetime
- 1980-03-31 PH PH23840A patent/PH17230A/en unknown
- 1980-04-01 DK DK140080A patent/DK149336C/da not_active IP Right Cessation
- 1980-04-01 AU AU57036/80A patent/AU533951B2/en not_active Expired
- 1980-04-01 CH CH256780A patent/CH655515B/it unknown
- 1980-04-02 ES ES490236A patent/ES490236A0/es active Granted
- 1980-04-03 SE SE8002601A patent/SE441188B/sv not_active IP Right Cessation
- 1980-04-03 BE BE0/200117A patent/BE882632A/fr not_active IP Right Cessation
- 1980-04-03 NL NL8001982A patent/NL192989C/nl not_active IP Right Cessation
- 1980-04-03 HU HU80822A patent/HU181534B/hu unknown
- 1980-04-03 LU LU82327A patent/LU82327A1/fr unknown
- 1980-04-03 PT PT71064A patent/PT71064A/pt unknown
- 1980-04-03 IT IT8021162A patent/IT1212411B/it active
- 1980-04-03 FR FR8007547A patent/FR2452931A1/fr active Granted
- 1980-04-03 DE DE19803013246 patent/DE3013246A1/de active Granted
- 1980-04-03 NZ NZ193357A patent/NZ193357A/xx unknown
- 1980-04-03 IE IE697/80A patent/IE49327B1/en not_active IP Right Cessation
- 1980-04-04 YU YU935/80A patent/YU41917B/xx unknown
- 1980-04-04 AT AT0187480A patent/AT370130B/de not_active IP Right Cessation
- 1980-04-07 MX MX808745U patent/MX5958E/es unknown
- 1980-04-07 JP JP4476480A patent/JPS5697237A/ja active Granted
- 1980-04-07 AR AR280577A patent/AR222217A1/es active
- 1980-04-08 CA CA000349360A patent/CA1142866A/en not_active Expired
- 1980-06-04 AU AU59036/80A patent/AU535727B2/en not_active Ceased
- 1980-12-11 US US06/215,310 patent/US4328316A/en not_active Expired - Lifetime
-
1984
- 1984-03-15 HK HK235/84A patent/HK23584A/xx not_active IP Right Cessation
-
1987
- 1987-03-06 SG SG226/87A patent/SG22687G/en unknown
- 1987-04-13 JP JP62088966A patent/JPS62282579A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6251274B2 (enEXAMPLES) | ||
| Asensio et al. | A new family of low molecular weight antibiotics from enterobacteria | |
| JPH0225919B2 (enEXAMPLES) | ||
| JPH0216756B2 (enEXAMPLES) | ||
| WO2015055107A1 (zh) | 一种游动放线菌菌株及其应用 | |
| EP1285928A1 (en) | Antibiotics tripropeptins and process for producing the same | |
| US3853709A (en) | Process for preparing nebramycin factors ii and vii | |
| JPH07102128B2 (ja) | ストレプトミセス・サンダエンシスの生物学的純粋培養物 | |
| KR970009151B1 (ko) | Ws-9326a, ws-9326b 화합물 및 그들의 유도체 | |
| GB2045231A (en) | Antibiotic A/16686 and its preparation from actinoplanes | |
| US4358584A (en) | Antibiotics A6888C and A6888X | |
| JPS5934355B2 (ja) | 醗酵方法 | |
| US4950605A (en) | FR-900493 substance, a process for its production and a pharmaceutical composition containing the same | |
| JP3107768B2 (ja) | デチオメチルδ１−Ｉ及び−Ｂｒ | |
| US3969501A (en) | Antibiotic 342-14-I and production thereof | |
| US4654211A (en) | New compound, FR-900451, production and use thereof | |
| US3467751A (en) | Antibiotic a195 and process for the preparation thereof | |
| KR830001443B1 (ko) | 항생물질 a/16686의 제법 | |
| CA1228313A (en) | Antibiotic sb 22 484 | |
| JPH029382A (ja) | 新抗生物質ｉｋｄ−８３４４物質及びその製造法並びにこれを有効成分とする抗腫瘍剤 | |
| JPH0361662B2 (enEXAMPLES) | ||
| KR790001337B1 (ko) | 가디마이신의 제조방법 | |
| JPH0631280B2 (ja) | Ｗｓ７７３９物質およびその製造法 | |
| JPH06343480A (ja) | Ｓｆ２３１５ａの製造法及びその薬学的用途 | |
| JPS6098987A (ja) | 抗生物質キチノボリン−ａおよびキチノボリン−ｂならびにその製造法 |